Search for: "Nycomed International Management GMBH"
Results 1 - 5 of 5
Sorted by Relevance | Sort by
Date
28 Apr, 2008 11:00 am
... second patent eligible for listing so should proceeds to hearing on the merits: Nycomed GmbH and
Nycomed Canada Inc v Minister of Health and Genpharm Inc: ... Israel boycott compliance: (IP Factor) Ukraine Defending well-known marks:
(International Law Office) United Arab Emirates Publication of registrations signals improvements in design ... clients on what's going to
happen': (IP ADR Blog), Association of University Technology Managers on prizes and patent pools: (IPBiz), Top ten patent cases: update ...
30 May, 2008 9:09 am
... (Pantoprazole) - Canada: Court dismisses motion to dismiss patent infringement proceeding on basis of abuse of process: Nycomed v Sandoz:
(Gowlings), Prevacid (Lansoprazole) - Canadian Court of Appeal upholds refusal to grant order prohibiting Minister ... Techdirt), (Ars Technica), (PLI), (Innovationpartners) Spain Court
confirms strict requirements for finding unfair imitation: (International Law Office), Alberto Casado named Director of OEPM (Spanish PTO):
(Class 46) Switzerland Swiss consumers ...
1 Feb, 2008 12:00 am
... as Impax moves closer to marketing a generic version of Opana: (IP Law360), Protonix (Pantoprazole) - Wyeth and Nycomed announce they will
launch generic version of Protonix: (Generic Pharmaceuticals & IP), (IP Law360), (IPNewsFlash ... generic version of Protonix: (Generic Pharmaceuticals & IP), (SmartBrief),
Selzentry (Maraviroc) - Pfizer agrees to give International Partnership for Microbicides a royalty-free license to Maraviroc, its
newly-approved HIV treatment: (SmartBrief), (more from ...
25 Oct, 2008 12:03 am
... decide whether Federal Circuit has jurisdiction to review appeal of district court's decision to remand case to state court (Managing Intellectual Property) US: Intellectual
property in a public health crisis (Patently-O) Products Abilify (Aripiprazole) - US: ... - EU: Court of First Instance hands down in decision in Aventis Pharma SA v Office for
Harmonisation in the Internal Market, Nycomed GmbH, an appeal involving a Community trade mark
opposition to PRAZOL (IPKat) Sustiva (Efavirenz) - Brazil: ...
31 Oct, 2008 11:53 am
... ) - EU: Court of First Instance hands down in decision in Aventis Pharma SA v Office for Harmonisation in the Internal Market, Nycomed GmbH, an appeal involving a Community trade mark opposition to PRAZOL (Managing Intellectual
Property) ReFacto / Xyntha (Antihemophilic Factor Recombinant) - US: Novartis files amended complaint against Wyeth in patent infringement suit over ReFacto and Xyntha (Law360)
Risperdal (Risperidone) ...
Search on: Blawgs.FM | BlawgSearch Google
Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!